Testing effectiveness (Phase 2)Study completedNCT03614078What this trial is testingPRCL-02 in Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis VulgarisPlaque Psoriasis PRCL Research Inc. 92
Not applicableLooking for participantsNCT07256015What this trial is testingDeucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in ItalyWho this might be right forPsoriasis Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT00443326What this trial is testingAMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsWho this might be right forPsoriasis Amgen 22
Large-scale testing (Phase 3)Study completedNCT01777191What this trial is testingEvaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 204
Post-approval studies (Phase 4)Ended earlyNCT05125679What this trial is testingEffect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen-Cilag Ltd. 15
Large-scale testing (Phase 3)Looking for participantsNCT07326813What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis InventisBio Co., Ltd 477
Large-scale testing (Phase 3)Ended earlyNCT04305327What this trial is testingEfficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque PsoriasisWho this might be right forPsoriasis LEO Pharma 12
Testing effectiveness (Phase 2)Study completedNCT00134394What this trial is testingEtanercept With Tacrolimus for PsoriasisWho this might be right forPsoriasis University of Medicine and Dentistry of New Jersey 20
Large-scale testing (Phase 3)Study completedNCT02325219What this trial is testingAn Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Janssen Pharmaceutical K.K. 192
Large-scale testing (Phase 3)Study completedNCT01235442What this trial is testingEvaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 592
Not applicableStudy completedNCT04655612What this trial is testingSeroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic DiseasesWho this might be right forCOVID-19SARS-CoV InfectionRheumatoid Arthritis+3 more University Hospital, Montpellier 5,000
Not applicableEnded earlyNCT00184366What this trial is testingClassification and Characterization of Patients Treated With Efalizumab for Plaque PsoriasisWho this might be right forPlaque Psoriasis Norwegian University of Science and Technology 96
Early research (Phase 1)Study completedNCT06738277What this trial is testingThis is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).Who this might be right forModerate to Severe Chronic Plaque Psoriasis Biocon Biologics UK Ltd 186
Post-approval studies (Phase 4)Study completedNCT03587194What this trial is testingEvaluation of Add on Enstilar in Patients Using Otezla for PsoriasisWho this might be right forPsoriasis Psoriasis Treatment Center of Central New Jersey 50
Not applicableLooking for participantsNCT04334031What this trial is testingDeployment o the Multidisciplinary Prospective Cohort ImminentWho this might be right forChronic Inflammatory DiseaseAngioedemaSevere Asthma+6 more University Hospital, Lille 2,200
Large-scale testing (Phase 3)Ended earlyNCT03556202What this trial is testingA Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)Who this might be right forPsoriasis Eli Lilly and Company 1,936
Testing effectiveness (Phase 2)Study completedNCT06073119What this trial is testingEvaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisWho this might be right forPsoriasis Sanofi 221
Large-scale testing (Phase 3)Study completedNCT03047395What this trial is testingAssess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )Who this might be right forPsoriasis AbbVie 2,170
Large-scale testing (Phase 3)Study completedNCT04435600What this trial is testingSubcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease SymptomsWho this might be right forPsoriasis AbbVie 139
Large-scale testing (Phase 3)Study completedNCT02684357What this trial is testingBI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AbbVie 577